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Effective hypothermia in critical care requires a strategy
to prevent and manage shivering. Core body temperature
in mammals is highly regulated [1]. Hypothermia leads to
the activation of measures to counteract this, reducing
heat loss through vasoconstriction and increasing heat
generation through increased metabolism and shivering.
Shivering resists the reduction in core temperature but
also increases physiological stresses, including an increase
in oxygen demand, catecholamine release and hyperten-
sion. It also can appear distressing, may be confused with
seizure activity and generally results in monitoring being
more difficult.
In the Eurotherm3235 trial [2], the prevention of shi-
vering required that patients were prepared for hypother-
mia appropriately, that shivering was detected early and
that a plan to treat shivering was followed should it be
detected. Patients were sedated with an opiate, propofol
and/or midazolam because anesthetic agents have been
shown to reduce the core temperature set point for
shivering. Regular paracetamol was also prescribed as
this reduces the hypothalamic temperature set point. The
hands and feet of patients were covered with towels,
which in addition to reducing the risk of thermal burns
has been shown to suppress shivering [3]. During
hypothermia, patients were observed closely for signs of
shivering, particularly in the jaw, neck and trunk as these
areas area the earliest to show signs of shivering [4].
On detection of possible shivering, seizures and inade-
quate sedation were excluded as causes of muscle move-
ments. Specific interventions included active skin
counter-warming with forced air convection as mean
skin temperature contributes around 20% to the control
of autonomic cold defenses, such as vasoconstriction
and shivering, and 50% to thermal comfort [5], or the
use of pethidine and the 2-agonist clonidine, each asso-
ciated with significant anti-shivering effects [6].
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